ATS View
한국어

D&D Pharmatech KRX:347850KOSDAQ

디앤디파마텍 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days4
DART filings, 7 days0
Articles tracked39since Sep 11

In Q2 2026, D&D Pharmatech reported revenue of ₩662m, down 28.4% year on year, and an operating loss of ₩9.9bn. D&D Pharmatech (디앤디파마텍) appeared in 4 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 23 with 6 articles. The most common catalyst was contracts & orders (1). It was most often mentioned alongside Isu Specialty Chemical, HBL and HanJungNCS.

Filing signals 4 quarters of losses Screener

D&D Pharmatech quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩662m-28.4%−₩9.9bn−₩7.8bn
Q1 2026₩129m-90.9%−₩11.1bn−₩10.1bn
Q4 2025 derived₩990m-80.4%−₩10.4bn₩1.9bn
Q3 2025₩969m-50.0%−₩6.2bn−₩5.8bn
Q2 2025₩925m-60.1%−₩8.1bn−₩10.0bn
Q1 2025₩1.4bn-32.8%−₩9.3bn−₩10.1bn
Q4 2024 derived₩5.1bn+180.0%−₩6.9bn
margin −135.7%		−₩9.8bn
Q3 2024₩1.9bn-72.3%−₩7.0bn−₩8.1bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

D&D Pharmatech top stories 2 weeks, by number of outlets

  1. 1
    [여의도 투자본부 2부] 한중엔시에스 vs 한빛레이저 vs 디앤디파마텍 vs 이수스페셜티케미컬, 공략법은?
    2 outlets · 2 articlesFirst report Oct 20 06:50 MTNHanJungNCSHBLIsu Specialty Chemical
  2. 2
    디앤디파마텍 이슬기 대표 "비만약 조기 기술이전…CNS·MASH는 2상 후 협력"
    1 outlets · 1 articlesFirst report Oct 29 08:30 PRESS9Licensing deal
  3. 3
    디앤디파마텍 경구 비만약 경쟁 가열…中 아슬레티스 ‘주 1회’ 도전
    1 outlets · 1 articlesFirst report Oct 21 06:50 메디코파마
  4. 4
    디앤디파마텍 NLY01, 뇌종양 병용요법서 항암 효과 확인
    1 outlets · 1 articlesFirst report Oct 23 08:32 메디파나뉴스
  5. 5
    디앤디파마텍, 'NLY01'·'보라시데닙' 병용 전임상서 IDH 변이 뇌종양 사멸 효과 확인
    1 outlets · 1 articlesFirst report Oct 23 10:33 팍스경제TV
  6. 6
    이슬기 디앤디파마텍 대표 “‘뉴코’, 자녀 결혼과 같아…매력적이지만 신중해야”
    1 outlets · 1 articlesFirst report Oct 29 15:00 더바이오

Latest D&D Pharmatech news Korean headlines